- Previous Close
60.97 - Open
61.92 - Bid --
- Ask --
- Day's Range
59.76 - 64.00 - 52 Week Range
34.80 - 92.00 - Volume
1,760,015 - Avg. Volume
1,011,653 - Market Cap (intraday)
5.24B - Beta (5Y Monthly) 0.16
- PE Ratio (TTM)
67.89 - EPS (TTM)
0.93 - Earnings Date Feb 10, 2025 - Feb 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It exports its products. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.
medicoremedies.com193
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: MEDICO.NS
View MorePerformance Overview: MEDICO.NS
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDICO.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDICO.NS
View MoreValuation Measures
Market Cap
5.23B
Enterprise Value
5.33B
Trailing P/E
67.89
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.73
Price/Book (mrq)
9.44
Enterprise Value/Revenue
3.82
Enterprise Value/EBITDA
31.12
Financial Highlights
Profitability and Income Statement
Profit Margin
5.93%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.44B
Net Income Avi to Common (ttm)
85.5M
Diluted EPS (ttm)
0.93
Balance Sheet and Cash Flow
Total Cash (mrq)
15.46M
Total Debt/Equity (mrq)
15.37%
Levered Free Cash Flow (ttm)
--